| NEUROCRINE BIOSCI. DL-001 |
| USA |
| Gesundheit |
| US64125C1099 / 900964 |
| NB3 (Frankfurt) / NBIX (NASDAQ) |
| FRA:NB3, ETR:NB3, NB3:GR, NASDAQ:NBIX |
| - |
| http://www.neurocrine.com.. |
|
Neurocrine Biosciences Inc. is a neuroscience-focused biopharmaceutical company specializing in the discovery, development, and commercialization of treatments for neurological, neuropsychiatric, endocrine, and metabolic disorders. Its flagship produ..
>Volltext.. |
| 11525.61 Mio. EUR |
| 10666.83 Mio. EUR |
| 2478.09 Mio. EUR |
| 577.49 Mio. EUR |
| 414.62 Mio. EUR |
| 4.17 EUR |
| 408.29 Mio. EUR |
| 617.68 Mio. EUR |
| 678.06 Mio. EUR |
| 1.99 |
| 7.05% |
| 23.6% |
| - |
| - |
| - |
| - |
| NEUROCRINE |
| 05.04.26 |